McManus Matthew has filed 20 insider transactions across 1 company since February 2024.
Most recent transaction: a option exercise of 4621 shares of BIO-TECHNE Corp ($TECH) on February 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | M | Common Stock | 4621 | $0.00 | 9,356.0000 | 156,999,000 | 97.59% | 0.00% |
| Feb. 1, 2026 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | M | Restricted Stock Units | 4621 | $0.00 | 19,517.0000 | 156,999,000 | 19.14% | 0.00% |
| Feb. 1, 2026 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | F | Common Stock | 1665 | $64.09 | 7,691.0000 | 156,999,000 | 17.80% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | A | Performance Restricted Stock Units | 19243 | $0.00 | 37,956.0000 | 159,717,000 | 102.83% | 0.01% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | A | Restricted Stock Units | 9622 | $0.00 | 18,863.0000 | 159,717,000 | 104.12% | 0.01% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | A | Stock Option (Right to Buy) | 24614 | $0.00 | 61,836.0000 | 159,717,000 | 66.13% | 0.02% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | M | Common Stock | 2637 | $0.00 | 5,615.0000 | 159,717,000 | 88.55% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | F | Common Stock | 880 | $53.60 | 4,735.0000 | 159,717,000 | 15.67% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - Diag & Spatial Bio | M | Restricted Stock Units | 2637 | $0.00 | 14,516.0000 | 159,717,000 | 15.37% | 0.00% |
| Feb. 1, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | M | Common Stock | 4620 | $0.00 | 4,620.0000 | 160,626,000 | 9999.99% | 0.00% |
| Feb. 1, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | F | Common Stock | 1642 | $73.55 | 2,978.0000 | 160,626,000 | 35.54% | 0.00% |
| Feb. 1, 2025 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | M | Restricted Stock Units | 4620 | $0.00 | 17,153.0000 | 160,626,000 | 21.22% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Performance Restricted Stock Units | 15825 | $0.00 | 15,825.0000 | 160,774,000 | 9999.99% | 0.01% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Stock Option (Right to Buy) | 21320 | $0.00 | 37,222.0000 | 160,774,000 | 134.07% | 0.01% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Performance Restricted Stock Units | 15818 | $0.00 | 18,706.0000 | 160,774,000 | 547.71% | 0.01% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Restricted Stock Units | 7912 | $0.00 | 21,773.0000 | 160,774,000 | 57.08% | 0.00% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Restricted Stock Units | 13861 | $0.00 | 13,861.0000 | 160,060,000 | 9999.99% | 0.01% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Restricted Stock Units | 2888 | $0.00 | 2,888.0000 | 160,060,000 | 9999.99% | 0.00% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Stock Option (Right to Buy) | 15902 | $0.00 | 15,902.0000 | 160,060,000 | 9999.99% | 0.01% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | McManus Matthew | President - DGS | A | Stock Option (Right to Buy) | 7951 | $0.00 | 7,951.0000 | 160,060,000 | 9999.99% | 0.00% |